Higher age (60 years) increases the risk for adverse events during autologous hematopoietic stem cell transplantation

HIGHLIGHTS

• who: Monika Haubitz and colleagues from the Laboratory for Hematopoiesis and Molecular Genetics, Experimental Hematology, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland have published the article: Higher Age (60 Years) Increases the Risk for Adverse Events during Autologous Hematopoietic Stem Cell Transplantation, in the Journal: Cancers 2023, 1584 of /2023/
• what: Based on the results , the authors propose that an increased focus should be laid on administrative, procedural, and qualitative aspects during autoHSCT to make substantial additional improvements and to further reduce the transplant-related risk especially also for older patients.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.